We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS).
- Authors
Gralla, Richard J; Edelman, Martin J; Detterbeck, Frank C; Jahan, Thierry M; Loesch, David M; Limentani, Steven A; Govindan, Ramaswamy; Peng, Guangbin; Monberg, Matthew J; Obasaju, Coleman K; Socinski, Mark A
- Abstract
The assessment of the impact of neoadjuvant therapy on quality of life (QL) has rarely been prospectively planned and evaluated, although validated QL instruments are available-such as the Lung Cancer Symptom Scale (LCSS) used in this study. The modest but significant survival gains reported with neoadjuvant and adjuvant approaches need to be viewed in terms of the added risks and toxicities associated with two or three modalities of treatment.
- Publication
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2009, Vol 17, Issue 3, p307
- ISSN
0941-4355
- Publication type
Journal Article
- DOI
10.1007/s00520-008-0489-y